# Strattec Security Corp: financial statements, quarterly

STRT · Nasdaq · CIK 933034 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jun 28

Pages: [Overview](/companies/strt.md) · [Financials](/companies/strt/financials.md) · [Filings](/companies/strt/filings.md) · [Insiders](/companies/strt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/strt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-01) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q4 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [135](/filings/0000950170-24-123365.md) | [119](/filings/0000950170-25-015878.md) | [141](/filings/0000950170-25-067538.md) | [143 d](/filings/0001193125-26-374333.md) | [139](/filings/0001193125-25-260138.md) | [130](/filings/0001193125-26-040760.md) | [144](/filings/0001193125-26-214153.md) | [152 d](/filings/0001193125-26-374333.md) | [152](/filings/0001193125-25-260138.md) | [138](/filings/0001193125-26-040760.md) | [138](/filings/0001193125-26-214153.md) | [152 d](/filings/0001193125-26-374333.md) |
| Cost of revenue | $m | [117](/filings/0000950170-24-123365.md) | [105](/filings/0000950170-25-015878.md) | [126](/filings/0000950170-25-067538.md) | [124 d](/filings/0001193125-26-374333.md) | [120](/filings/0001193125-25-260138.md) | [113](/filings/0001193125-26-040760.md) | [121](/filings/0001193125-26-214153.md) | [127 d](/filings/0001193125-26-374333.md) | [126](/filings/0001193125-25-260138.md) | [115](/filings/0001193125-26-040760.md) | [115](/filings/0001193125-26-214153.md) | [128 d](/filings/0001193125-26-374333.md) |
| Gross profit | $m | [18.7](/filings/0000950170-24-123365.md) | [13.5](/filings/0000950170-25-015878.md) | [14.7](/filings/0000950170-25-067538.md) | [18.6 d](/filings/0001193125-26-374333.md) | [18.9](/filings/0001193125-25-260138.md) | [17.2](/filings/0001193125-26-040760.md) | [23.1](/filings/0001193125-26-214153.md) | [25.4 d](/filings/0001193125-26-374333.md) | [26.3](/filings/0001193125-25-260138.md) | [22.7](/filings/0001193125-26-040760.md) | [22.7](/filings/0001193125-26-214153.md) | [23.6 d](/filings/0001193125-26-374333.md) |
| Operating income | $m | [6.1](/filings/0000950170-24-123365.md) | [0.1](/filings/0000950170-25-015878.md) | [2.0](/filings/0000950170-25-067538.md) | [9.7 d](/filings/0001193125-26-374333.md) | [5.1](/filings/0001193125-25-260138.md) | [2.1](/filings/0001193125-26-040760.md) | [7.1](/filings/0001193125-26-214153.md) | [8.5 d](/filings/0001193125-26-374333.md) | [10.4](/filings/0001193125-25-260138.md) | [4.9](/filings/0001193125-26-040760.md) | [5.0](/filings/0001193125-26-214153.md) | [6.2 d](/filings/0001193125-26-374333.md) |
| Interest expense | $m | [0.2](/filings/0000950170-24-123365.md) | [0.2](/filings/0000950170-25-015878.md) | [0.2](/filings/0000950170-25-067538.md) | [0.2 d](/filings/0001193125-26-374333.md) | [0.3](/filings/0001193125-25-260138.md) | [0.3](/filings/0001193125-26-040760.md) | [0.2](/filings/0001193125-26-214153.md) | [0.2 d](/filings/0001193125-26-374333.md) | [0.2](/filings/0001193125-25-260138.md) | [0.1](/filings/0001193125-26-040760.md) | [0.1](/filings/0001193125-26-214153.md) | [0.0 d](/filings/0001193125-26-374333.md) |
| Income tax | $m | [1.4](/filings/0000950170-24-123365.md) | [0.3](/filings/0000950170-25-015878.md) | [0.5](/filings/0000950170-25-067538.md) | [1.6 d](/filings/0001193125-26-374333.md) | [1.5](/filings/0001193125-25-260138.md) | [0.4](/filings/0001193125-26-040760.md) | [1.6](/filings/0001193125-26-214153.md) | [2.2 d](/filings/0001193125-26-374333.md) | [2.4](/filings/0001193125-25-260138.md) | [1.7](/filings/0001193125-26-040760.md) | [1.3](/filings/0001193125-26-214153.md) | [6.0 d](/filings/0001193125-26-374333.md) |
| Net income | $m | [4.2](/filings/0000950170-24-123365.md) | [1.0](/filings/0000950170-25-015878.md) | [1.5](/filings/0000950170-25-067538.md) | [9.6 d](/filings/0001193125-26-374333.md) | [3.7](/filings/0001193125-25-260138.md) | [1.3](/filings/0001193125-26-040760.md) | [5.4](/filings/0001193125-26-214153.md) | [8.3 d](/filings/0001193125-26-374333.md) | [8.5](/filings/0001193125-25-260138.md) | [4.9](/filings/0001193125-26-040760.md) | [3.2](/filings/0001193125-26-214153.md) | [3.9 d](/filings/0001193125-26-374333.md) |
| Diluted EPS | $ per share | [1.05](/filings/0000950170-24-123365.md) | [0.26](/filings/0000950170-25-015878.md) | [0.37](/filings/0000950170-25-067538.md) | not reported | [0.92](/filings/0001193125-25-260138.md) | [0.32](/filings/0001193125-26-040760.md) | [1.32](/filings/0001193125-26-214153.md) | not reported | [2.07](/filings/0001193125-25-260138.md) | [1.20](/filings/0001193125-26-040760.md) | [0.78](/filings/0001193125-26-214153.md) | not reported |
| Basic EPS | $ per share | [1.05](/filings/0000950170-24-123365.md) | [0.26](/filings/0000950170-25-015878.md) | [0.38](/filings/0000950170-25-067538.md) | not reported | [0.92](/filings/0001193125-25-260138.md) | [0.33](/filings/0001193125-26-040760.md) | [1.34](/filings/0001193125-26-214153.md) | not reported | [2.10](/filings/0001193125-25-260138.md) | [1.21](/filings/0001193125-26-040760.md) | [0.79](/filings/0001193125-26-214153.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-01) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [15.7](/filings/0000950170-23-061464.md) | [11.6](/filings/0000950170-24-012813.md) | [9.6](/filings/0000950170-24-056833.md) | [25.4](/filings/0000950170-25-111218.md) | [34.4](/filings/0000950170-24-123365.md) | [42.6](/filings/0000950170-25-015878.md) | [62.1](/filings/0000950170-25-067538.md) | [84.6](/filings/0001193125-26-374333.md) | [90.5](/filings/0001193125-25-260138.md) | [99.0](/filings/0001193125-26-040760.md) | [107](/filings/0001193125-26-214153.md) | [108](/filings/0001193125-26-374333.md) |
| Current assets | $m | [228](/filings/0000950170-23-061464.md) | [222](/filings/0000950170-24-012813.md) | [241](/filings/0000950170-24-056833.md) | [254](/filings/0000950170-25-111218.md) | [261](/filings/0000950170-24-123365.md) | [254](/filings/0000950170-25-015878.md) | [287](/filings/0000950170-25-067538.md) | [290](/filings/0001193125-26-374333.md) | [290](/filings/0001193125-25-260138.md) | [293](/filings/0001193125-26-040760.md) | [304](/filings/0001193125-26-214153.md) | [296](/filings/0001193125-26-374333.md) |
| Total assets | $m | [341](/filings/0000950170-23-061464.md) | [332](/filings/0000950170-24-012813.md) | [349](/filings/0000950170-24-056833.md) | [364](/filings/0000950170-25-111218.md) | [367](/filings/0000950170-24-123365.md) | [356](/filings/0000950170-25-015878.md) | [387](/filings/0000950170-25-067538.md) | [391](/filings/0001193125-26-374333.md) | [390](/filings/0001193125-25-260138.md) | [392](/filings/0001193125-26-040760.md) | [400](/filings/0001193125-26-214153.md) | [387](/filings/0001193125-26-374333.md) |
| Current liabilities | $m | [117](/filings/0000950170-23-061464.md) | [106](/filings/0000950170-24-012813.md) | [121](/filings/0000950170-24-056833.md) | [118](/filings/0000950170-25-111218.md) | [120](/filings/0000950170-24-123365.md) | [97.6](/filings/0000950170-25-015878.md) | [123](/filings/0000950170-25-067538.md) | [119](/filings/0001193125-26-374333.md) | [117](/filings/0001193125-25-260138.md) | [112](/filings/0001193125-26-040760.md) | [116](/filings/0001193125-26-214153.md) | [102](/filings/0001193125-26-374333.md) |
| Total liabilities | $m | not reported | not reported | not reported | [139](/filings/0000950170-25-111218.md) | not reported | not reported | not reported | [145](/filings/0001193125-26-374333.md) | [134](/filings/0001193125-25-260138.md) | [129](/filings/0001193125-26-040760.md) | [132](/filings/0001193125-26-214153.md) | [122](/filings/0001193125-26-374333.md) |
| Shareholders' equity | $m | [189](/filings/0000950170-23-061464.md) | [191](/filings/0000950170-24-012813.md) | [194](/filings/0000950170-24-056833.md) | [201](/filings/0000950170-25-111218.md) | [203](/filings/0000950170-24-123365.md) | [205](/filings/0000950170-25-015878.md) | [211](/filings/0000950170-25-067538.md) | [222](/filings/0001193125-26-374333.md) | [231](/filings/0001193125-25-260138.md) | [237](/filings/0001193125-26-040760.md) | [241](/filings/0001193125-26-214153.md) | [239](/filings/0001193125-26-374333.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-01) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q4 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.9)](/filings/0000950170-24-123365.md) | [(3.0) d](/filings/0000950170-25-015878.md) | [(0.3) d](/filings/0000950170-25-067538.md) | [19.5 d](/filings/0001193125-26-374333.md) | [11.3](/filings/0001193125-25-260138.md) | [9.4 d](/filings/0001193125-26-040760.md) | [20.7 d](/filings/0001193125-26-214153.md) | [30.2 d](/filings/0001193125-26-374333.md) | [11.3](/filings/0001193125-25-260138.md) | [13.9 d](/filings/0001193125-26-040760.md) | [11.4 d](/filings/0001193125-26-214153.md) | [9.7 d](/filings/0001193125-26-374333.md) |
| Capital expenditure | $m | [2.9](/filings/0000950170-24-123365.md) | [1.5 d](/filings/0000950170-25-015878.md) | [1.7 d](/filings/0000950170-25-067538.md) | [3.7 d](/filings/0001193125-26-374333.md) | [2.1](/filings/0001193125-25-260138.md) | [0.9 d](/filings/0001193125-26-040760.md) | [1.2 d](/filings/0001193125-26-214153.md) | [3.0 d](/filings/0001193125-26-374333.md) | [1.5](/filings/0001193125-25-260138.md) | [2.6 d](/filings/0001193125-26-040760.md) | [1.8 d](/filings/0001193125-26-214153.md) | [1.4 d](/filings/0001193125-26-374333.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-02) | Q2 FY2023 (2023-01-01) | Q3 FY2023 (2023-04-02) | Q1 FY2024 (2023-10-01) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,929](/filings/0000950170-23-061464.md) | [3,927](/filings/0000950170-24-012813.md) | [3,928](/filings/0000950170-24-056833.md) | [3,974](/filings/0000950170-24-123365.md) | [3,998](/filings/0000950170-25-015878.md) | [4,017](/filings/0000950170-25-067538.md) | [4,046](/filings/0001193125-25-260138.md) | [4,070](/filings/0001193125-26-040760.md) | [4,085](/filings/0001193125-26-214153.md) | [4,127](/filings/0001193125-25-260138.md) | [4,131](/filings/0001193125-26-040760.md) | [4,141](/filings/0001193125-26-214153.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,985,013 at 2026-07-31, from the cover of the [10-K filed 2026-08-28](/filings/0001193125-26-374333.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.